2011
DOI: 10.1177/147323001103900510
|View full text |Cite
|
Sign up to set email alerts
|

Silencing of X-Linked Inhibitor of Apoptosis Decreases Resistance to Cisplatin and Paclitaxel but Not Gemcitabine in Non-Small Cell Lung Cancer

Abstract: Non-small cell lung cancer (NSCLC) is a highly lethal malignancy that often becomes resistant to chemotherapy. The effect of silencing the X-linked inhibitor of apoptosis gene (XIAP) on resistance to cisplatin, paclitaxel and gemcitabine was studied in the NSCLC cell lines A549 and H460. Transfection of these cells with small interfering RNA (siRNA) for XIAP blocked overexpression of the gene, suppressed cell proliferation, increased apoptosis and increased the cells' sensitivity to cisplatin and paclitaxel b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 29 publications
1
10
0
Order By: Relevance
“…There is abundant research focusing on XIAP depletion or knockdown in cancer cells leading to reduction in cell migration and invasion (7,29). Molecular approaches for targeting XIAP expression include phosphorothioate antisense oligonucleotide (AEG-35156)-targeted XIAP mRNA (30), small interfering RNA (siRNA) (31), and a small molecule inhibitor of XIAP (32). However, safety is the major limitation of the aforementioned approaches, along with other concerns such as poor stability, membrane penetration, and transfection efficiency (33).…”
Section: Discussionmentioning
confidence: 99%
“…There is abundant research focusing on XIAP depletion or knockdown in cancer cells leading to reduction in cell migration and invasion (7,29). Molecular approaches for targeting XIAP expression include phosphorothioate antisense oligonucleotide (AEG-35156)-targeted XIAP mRNA (30), small interfering RNA (siRNA) (31), and a small molecule inhibitor of XIAP (32). However, safety is the major limitation of the aforementioned approaches, along with other concerns such as poor stability, membrane penetration, and transfection efficiency (33).…”
Section: Discussionmentioning
confidence: 99%
“…Western blot analysis was conducted as previously study [16,17]. Briefly, 50 mg total proteins from samples was separated on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis gels and transferred to PVDF membranes (Millipore Corp., USA).…”
Section: Western Blot Analysismentioning
confidence: 99%
“…The sequences of XIAP siRNA were described previously [16]. The transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.…”
Section: Sirna Transfectionmentioning
confidence: 99%
“…For example, the antiapoptotic proteins BCL2 and XIAP are of minor importance in EJ28 and J82 BCa cells, while Bcl-xL and survivin seem to be most important [6]. However, in other tumor entities, such as gastric cancer and non-small cell lung cancer, siRNA-mediated knockdown of BCL2 and XIAP, respectively, induced apoptosis and reduced tumor growth [24,25]. Likewise, even though the phosphatidylinositol 3-kinase (PI3K) p110 isoforms α and β are both upregulated in paclitaxel-resistant ovarian cancer cells only the siRNA-mediated knockdown of PI3K p110β resensitized these cells towards paclitaxel [26].…”
Section: Resultsmentioning
confidence: 99%